Showing 1 - 10 of 148
Persistent link: https://www.econbiz.de/10000767407
Persistent link: https://www.econbiz.de/10000739478
Persistent link: https://www.econbiz.de/10001290861
Persistent link: https://www.econbiz.de/10004800631
Persistent link: https://www.econbiz.de/10013456290
Objective: Data from the Acute Infarction Ramipril Efficacy (AIRE) study were used in a cost-effectiveness analysis to determine the incremental cost per life-year gained (LYG) when the ACE inhibitor ramipril was added to conventional treatment in patients with heart failure after acute...
Persistent link: https://www.econbiz.de/10005449120
Alcoholism places a considerable economic burden on society. The rate of relapse of previously weaned alcoholics has been shown to decrease following treatment with acamprosate. Therefore, this study investigated the cost effectiveness of acamprosate in the treatment of alcoholism in Germany...
Persistent link: https://www.econbiz.de/10005404846
The Cardiac Insufficiency Bisoprolol Study (CIBIS) demonstrates that, for patients with heart failure of different aetiologies, administration of the beta1-adrenoceptor blocker bisoprolol as an adjuvant to the standard therapy leads to a significant avoidance of hospital admissions. A...
Persistent link: https://www.econbiz.de/10005590513